Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DAO | P14920 | 1/20 | 0.63 |
| ▸ | CES2 | O00748 | 1/20 | 0.59 |
| ▸ | CES1 | P23141 | 1/20 | 0.59 |
| ▸ | NPSR1 | Q6W5P4 | 4/20 | 0.56 |
| ▸ | PPARG | P37231 | 2/20 | 0.56 |
| ▸ | NCOA1 | Q15788 | 2/20 | 0.56 |
| ▸ | NCOA3 | Q9Y6Q9 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 1/20 | 0.56 |
| ▸ | NCOA2 | Q15596 | 1/20 | 0.56 |
| ▸ | GSK3B | P49841 | 2/20 | 0.52 |
| ▸ | HPGD | P15428 | 3/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.50 |
| ▸ | TSHR | P16473 | 1/20 | 0.50 |
| ▸ | ATM | Q13315 | 1/20 | 0.50 |
| ▸ | GAA | P10253 | 1/20 | 0.50 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.50 |
| ▸ | USP2 | O75604 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23407055 | 0.89 | NPSR1 (0.50) | DAOCES2CES1NPSR1PPARG | |
| SCHEMBL70027 | 0.84 | NPSR1 (0.67) | DAONPSR1PPARGNCOA1NCOA3 | |
| SCHEMBL7651777 | 0.83 | CES2 (0.64) | DAOCES2CES1NPSR1PPARG | |
| SCHEMBL64687 | 0.79 | HDAC3 (0.58) | DAOCES2CES1NPSR1PPARG | |
| SCHEMBL5043396 | 0.79 | CES2 (0.53) | DAOCES2CES1NPSR1PPARG | |
| SCHEMBL1235256 | 0.78 | LMNA (0.60) | NPSR1PPARGNCOA1NCOA3LMNA | |
| SCHEMBL1303016 | 0.78 | NPSR1 (0.60) | DAONPSR1PPARGNCOA1NCOA3 | |
| SCHEMBL71972 | 0.78 | — | — | |
| SCHEMBL3347072 | 0.77 | GSK3B (0.59) | DAOCES2CES1NPSR1PPARG | |
| SCHEMBL3958438 | 0.77 | HDAC3 (0.57) | DAOCES2CES1NPSR1PPARG |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 661 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118620231-B | Luminescent metal organic frame material, preparation method thereof and application thereof in nitrofuran antibiotic detection | 江苏师范大学 | 2024-11-15 | — | — | CN | claimed |
| CN-118620231-A | Luminescent metal organic frame material, preparation method thereof and application thereof in nitrofuran antibiotic detection | 江苏师范大学 | 2024-09-10 | — | — | CN | claimed |
| CN-116239586-A | Thienyl-containing organic semiconductor crystal material and preparation method and application thereof | 宁波大学 | 2023-06-09 | — | — | CN | claimed |
| CN-114044905-B | Preparation method of end-group functionalized polydimethylsiloxane | 复旦大学 | 2023-01-06 | — | — | CN | claimed |
| CN-115403601-A | Microenvironment sensitive fluorescent dye for detecting A beta fibril and preparation method thereof | 常州工学院 | 2022-11-29 | — | — | CN | claimed |
| CN-114044905-A | Preparation method of end group functionalized polydimethylsiloxane | 复旦大学 | 2022-02-15 | — | — | CN | claimed |
| CN-105111197-B | Synthesis method of raltitrexed | 上海鼎雅药物化学科技有限公司 | 2021-05-04 | — | — | CN | claimed |
| EP-3747957-A1 | FLUORESCENT VINYL TIOPHENE AND BITIOPHENE COUMARINS DYES AND METHOD OF SYNTHESIS THEREOF | Universidade de Évora (PT) | 2020-12-09 | — | — | EP | claimed |
| WO-2026086812-A1 | INHIBITORS OF MENIN | RONGCHANG PHARMACEUTICALS, LTD. (CN) | 2026-04-30 | — | — | WO | disclosed |
| WO-2026086915-A1 | GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE RECEPTOR (GIPR) ANTAGONISTS AND METHODS OF USES THEREOF | INSILICO MEDICINE IP LIMITED (CN) | 2026-04-30 | — | — | WO | disclosed |
| US-20250361244-A1 | BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS | AURIGENE ONCOLOGY LTD (IN) | 2025-11-27 | — | — | US | disclosed |
| EP-4650002-A1 | ANILINE-BASED MODULATORS OF THE NUCLEAR RECEPTOR TLX (NR2E1) | Ludwig-Maximilians-Universität (DE) | 2025-11-19 | — | — | EP | disclosed |
| US-12410193-B2 | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors | AURIGENE ONCOLOGY LIMITED (IN) | 2025-09-09 | — | — | US | disclosed |
| EP-4573092-A1 | 2,3,4,9-TETRAHYDRO-1H-PYRIDO[3,4-B]INDOLE DERIVATIVES AS ESTROGEN RECEPTOR MODULATORS FOR THE TREATMENT OF CANCER | Olema Pharmaceuticals, Inc. (US) | 2025-06-25 | — | — | EP | disclosed |
| EP-0679630-A1 | Bicyclic aromatic compounds, pharmaceutical and cosmetic compositions containing them and uses | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (C.I.R.D. GALDERMA) (FR) | 1995-11-02 | — | — | EP | disclosed |
| EP-0674516-A4 | — | — | 1995-10-25 | — | — | EP | disclosed |
| EP-0674516-A1 | ANTIPROLIFERATIVE SUBSTITUTED 5-THIAPYRIMIDINONE AND 5-SELENOPYRIMIDINONE COMPOUNDS | AGOURON PHARMACEUTICALS, INC. (US) | 1995-10-04 | — | — | EP | disclosed |
| US-5434180-A | Skin disorders; retinoid activity; rheumatoid psoriasis; | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) | 1995-07-18 | — | — | US | disclosed |
| WO-1994013295-A1 | ANTIPROLIFERATIVE SUBSTITUTED 5-THIAPYRIMIDINONE AND 5-SELENOPYRIMIDINONE COMPOUNDS | AGOURON PHARMACEUTICALS, INC. (US) | 1994-06-23 | — | — | WO | disclosed |
| US-5124473-A | Skin disorders; antiinflammatory agents, antiallergens | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES GALDERMA (CIRD GALDERMA) (FR) | 1992-06-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12410193-B2 | Bicyclic heterocyclyl derivatives as IRAK4 inhibitors | IRAK4, IRAK3, IRAK1 | DAO 3454/4885CES2 2503/4885CES1 834/4885 |
| US-20250361244-A1 | BICYCLIC HETEROCYCLYL DERIVATIVES AS IRAK4 INHIBITORS | IRAK4, IRAK3, IRAK1 | DAO 3454/4885CES2 2503/4885CES1 834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.